8PO2
Discovery and Optimisation of Potent, Efficacious and Selective Inhibitors Targeting EGFR Exon20 Insertion Mutations. Compound 33 bound to EGFRinsNPG [V948R]
Entity
Entity ID | Chain ID | Description | Type | Chain length | Formula weight | Number of molecules | DB Name (Accession) | Biological source | Descriptive keywords |
1 | A, B, D | Epidermal growth factor receptor | polymer | 332 | 37774.6 | 3 | UniProt (P00533) Pfam (PF07714) In PDB | Homo sapiens (human) | Proto-oncogene c-ErbB-1,Receptor tyrosine-protein kinase erbB-1 |
2 | A, B | 1-cyclopropyl-~{N}-[3-[1-(1-propanoylazetidin-3-yl)-4-pyridin-4-yl-pyrazol-3-yl]phenyl]imidazole-4-carboxamide | non-polymer | 481.5 | 2 | Chemie (26X) | |||
3 | water | water | 18.0 | 228 | Chemie (HOH) |
Sequence modifications
A, B, D: 695 - 1025 (UniProt: P00533)
PDB | External Database | Details |
---|---|---|
Gly 694 | - | expression tag |
Gly 773 | - | insertion |
Asn 774 | - | insertion |
Pro 775 | - | insertion |
Arg 951 | Val 948 | engineered mutation |
Sequence viewer
Contents of the asymmetric unit
Polymers | Number of chains | 3 |
Total formula weight | 113323.8 | |
Non-Polymers* | Number of molecules | 2 |
Total formula weight | 963.1 | |
All* | Total formula weight | 114286.9 |